BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35312790)

  • 41. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.
    Ehrmann S; Quartin A; Hobbs BP; Robert-Edan V; Cely C; Bell C; Lyons G; Pham T; Schein R; Geng Y; Lakhal K; Ng CS
    Intensive Care Med; 2017 Jun; 43(6):785-794. PubMed ID: 28197679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
    van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
    Eur Radiol; 2018 Jul; 28(7):2845-2855. PubMed ID: 29426991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shortage of iodinated contrast media: Status and possible chances - A systematic review.
    Koeppel DR; Boehm IB
    Eur J Radiol; 2023 Jul; 164():110853. PubMed ID: 37156181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
    Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
    Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for post-contrast acute kidney injury in patients sequentially administered iodine- and gadolinium-based contrast media on the same visit to the emergency department: a retrospective study.
    Kang C; Han SH; Park JS; Choi DE
    Kidney Res Clin Pract; 2023 May; 42(3):358-369. PubMed ID: 37098667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
    Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
    Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
    Chaudhury P; Armanyous S; Harb SC; Ferreira Provenzano L; Ashour T; Jolly SE; Arrigain S; Konig V; Schold JD; Navaneethan SD; Nally JV; Nakhoul GN
    Nephron; 2019; 141(1):31-40. PubMed ID: 30368506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?
    De Simone B; Ansaloni L; Sartelli M; Gaiani F; Leandro G; De' Angelis GL; Di Mario F; Coccolini F; Catena F
    Acta Biomed; 2018 Dec; 89(9-S):158-172. PubMed ID: 30561410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System.
    Blumenthal KG; Lai KH; Huang M; Wallace ZS; Wickner PG; Zhou L
    J Allergy Clin Immunol Pract; 2017; 5(3):737-743.e3. PubMed ID: 28110055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis.
    Hsieh C; Wu SC; Kosik RO; Huang YC; Chan WP
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iodinated Contrast Media Substitution to Prevent Recurrent Hypersensitivity Reactions: A Systematic Review and Meta-Analysis.
    Umakoshi H; Nihashi T; Takada A; Hirasawa N; Ishihara S; Takehara Y; Naganawa S; Davenport MS; Terasawa T
    Radiology; 2022 Nov; 305(2):341-349. PubMed ID: 35852428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of non-ionic contrast media in CT examinations for out-patients: retrospective multicenter analysis of 473,482 patients.
    Zeng W; Tang J; Xu X; Zhang Y; Zeng L; Zhang Y; Liang Z; Xia C; Zhao L; Li Z
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38457038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child.
    Zuckerman GB; Riess PL; Patel L; Constantinescu AR; Rosenfeld DL
    Pediatr Radiol; 1999 Apr; 29(4):295-7. PubMed ID: 10199911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients.
    Song W; Zhang T; Pu J; Shen L; He B
    Clin Interv Aging; 2014; 9():85-93. PubMed ID: 24403826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media.
    Wu YW; Leow KS; Zhu Y; Tan CH
    Ann Acad Med Singap; 2016 Apr; 45(4):157-64. PubMed ID: 27292007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors and Outcomes of Postcontrast Acute Kidney Injury after Endovascular Renal Artery Intervention.
    Takahashi EA; Kallmes DF; Fleming CJ; McDonald RJ; McKusick MA; Bjarnason H; Harmsen WS; Misra S
    J Vasc Interv Radiol; 2017 Dec; 28(12):1687-1692. PubMed ID: 28947366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An observational study to evaluate the efficiency and safety of ioversol pre-filled syringes compared with ioversol bottles in contrast-enhanced examinations.
    Vogl TJ; Wessling J; Buerke B
    Acta Radiol; 2012 Oct; 53(8):914-20. PubMed ID: 22983259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study.
    Demel SL; Grossman AW; Khoury JC; Moomaw CJ; Alwell K; Kissela BM; Woo D; Flaherty ML; Ferioli S; Mackey J; De Los Rios la Rosa F; Martini S; Adeoye O; Kleindorfer DO
    Stroke; 2017 Apr; 48(4):835-839. PubMed ID: 28258258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.